Global and United States Nucleic Acid Delivery Excipients Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global and United States Nucleic Acid Delivery Excipients Market Report & Forecast 2024-2034
Nucleic acids, including plasmid DNA, oligonucleotides, small interfering RNA, messenger RNA and micro RNA provide significant promise in the treatment of challenging diseases. Unfortunately, their delivery as therapeutic agents has been a challenge. Nanoparticulate delivery systems, in which cationic lipids or polymers condense nucleic acids to form “lipoplex” or “polyplex” via the negative phosphate groups of nucleic acids show high productivity and loading efficiency. The intracellular delivery of these complexes is believed to occur via endocytosis followed by endosomal escape into the cytoplasm.
Market Analysis and InsightsGlobal and United States Nucleic Acid Delivery Excipients Market
This report focuses on global and United States Nucleic Acid Delivery Excipients market, also covers the segmentation data of other regions in regional level and county level.
The global Nucleic Acid Delivery Excipients revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during the forecast period (2024-2034).
In United States the Nucleic Acid Delivery Excipients revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2024-2034).
The global key players of Nucleic Acid Delivery Excipients include Avanti Polar Lipids, Alfa Chemistry, Evonik Health Care, Phosphorex, Creative Biolabs, Celares, VectorBuilder, Seqens and BroadPharm, etc. The global five biggest players hold a share of % in 2022.
Global Nucleic Acid Delivery Excipients Scope and Market Size
Nucleic Acid Delivery Excipients market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Nucleic Acid Delivery Excipients market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For United States market, this report focuses on the Nucleic Acid Delivery Excipients market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in United States.

Avanti Polar Lipids
Alfa Chemistry
Evonik Health Care
Phosphorex
Creative Biolabs
Celares
VectorBuilder
Seqens
BroadPharm
Entos
Gattefossé
Segment by Type
Cationic Lipids
pH-sensitive Lipids
Phospholipids
PEG Lipids
Lipid Nanoparticles for mRNA/siRNA/DNA
Transfection Vectors for Gene Therapies
Immunotherapies (CAR-T-Cells)
Lipid Prodrugs
Liposome Vectorization for Oncology
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Nucleic Acid Delivery Excipients definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Nucleic Acid Delivery Excipients companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Nucleic Acid Delivery Excipients in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nucleic Acid Delivery Excipients sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion
Market Analysis and InsightsGlobal and United States Nucleic Acid Delivery Excipients Market
This report focuses on global and United States Nucleic Acid Delivery Excipients market, also covers the segmentation data of other regions in regional level and county level.
The global Nucleic Acid Delivery Excipients revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during the forecast period (2024-2034).
In United States the Nucleic Acid Delivery Excipients revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2024-2034).
The global key players of Nucleic Acid Delivery Excipients include Avanti Polar Lipids, Alfa Chemistry, Evonik Health Care, Phosphorex, Creative Biolabs, Celares, VectorBuilder, Seqens and BroadPharm, etc. The global five biggest players hold a share of % in 2022.
Global Nucleic Acid Delivery Excipients Scope and Market Size
Nucleic Acid Delivery Excipients market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Nucleic Acid Delivery Excipients market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For United States market, this report focuses on the Nucleic Acid Delivery Excipients market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in United States.

By Company
Avanti Polar Lipids
Alfa Chemistry
Evonik Health Care
Phosphorex
Creative Biolabs
Celares
VectorBuilder
Seqens
BroadPharm
Entos
Gattefossé
Segment by Type
Cationic Lipids
pH-sensitive Lipids
Phospholipids
PEG Lipids
Segment by Application
Lipid Nanoparticles for mRNA/siRNA/DNA
Transfection Vectors for Gene Therapies
Immunotherapies (CAR-T-Cells)
Lipid Prodrugs
Liposome Vectorization for Oncology
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Nucleic Acid Delivery Excipients definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Nucleic Acid Delivery Excipients companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Nucleic Acid Delivery Excipients in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nucleic Acid Delivery Excipients sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion
